Vaginal Ring for Hormone Therapy, Prevention of Preterm Labor & Luteal Phase Support During ART

Time: 2:45 pm
day: Day 1


  • Focusing on use of a novel segmented intravaginal ring (IVR) to deliver estradiol and progesterone over 28 days for treatment of vasomotor symptoms associated with the menopause
  • Exploring the segmented IVR to reduce the incidence of preterm labor by delivery of vaginal progesterone
  • Understanding the use of the segmented IVR for its use in the luteal phase support during ART including combinations with injectable progesterone